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Abstract.
Background: Bacterial infections may be associated with dementia, but the temporality of any relationship remains unclear.
Objectives: To summarize existing literature on the association between common bacterial infections and the risk of dementia
and cognitive decline in longitudinal studies.
Methods: We performed a comprehensive search of 10 databases of published and grey literature from inception to 18 March
2019 using search terms for common bacterial infections, dementia, cognitive decline, and longitudinal study designs. Two
reviewers independently performed the study selection, data extraction, risk of bias and overall quality assessment. Data were
summarized through a narrative synthesis as high heterogeneity precluded a meta-analysis.
Results: We identified 3,488 studies. 9 met the eligibility criteria; 6 were conducted in the United States and 3 in Taiwan.
7 studies reported on dementia and 2 investigated cognitive decline. Multiple infections were assessed in two studies. All
studies found sepsis (n = 6), pneumonia (n = 3), urinary tract infection (n = 1), and cellulitis (n = 1) increased dementia risk
(HR 1.10; 95% CI 1.02–1.19) to (OR 2.60; 95% CI 1.84–3.66). The range of effect estimates was similar when limited to
three studies with no domains at high risk of bias. However, the overall quality of evidence was rated very low. Studies on
cognitive decline found no association with infection but had low power.
Conclusion: Our review suggests common bacterial infections may be associated with an increased risk of subsequent
dementia, after adjustment for multiple confounders, but further high-quality, large-scale longitudinal studies, across different
healthcare settings, are recommended to further explore this association.
Keywords: Cognition, dementia, infections, prevention, systematic review
Systematic review registration number: CRD42018119294, registered in December 2018
INTRODUCTION
Dementia is a major global health challenge.
Worldwide, approximately 50 million people are
∗Correspondence to: Rutendo Muzambi, Faculty of Epidemi-
ology and Population Health, London School of Hygiene and
Tropical Medicine, London, WC1E 7HT, UK. Tel.: +44 0 20 7299
4678; E-mail: rutendo.muzambi@lshtm.ac.uk.
currently living with dementia, and this number is
projected to rise to over 152 million by 2050 [1].
Given the increasing life expectancy and absence
of a cure or disease-modifying therapy, dementia
prevention has become a public health priority [2].
Recent evidence suggests modifiable risk factors may
have contributed to a decline in the age-specific
incidence of dementia in Europe and the United
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States [3–9], highlighting the importance of identi-
fying and targeting modifiable risk factors, as age
increases. Bacterial infections have been identified
as one potentially important risk factor for dementia
[10, 11].
Symptomatic bacterial infections such as pneumo-
nia and urinary tract infections are common, and
complications frequently occur among older peo-
ple. One of the hallmark complications of common
bacterial infections is delirium; a serious neuropsy-
chiatric syndrome characterized by acute cognitive
dysfunction and inattention [12]. Delirium is strongly
associated with an increased risk of subsequent
cognitive decline and dementia [13–15]. Increasing
evidence suggests cognitive impairment may persist
for years after sepsis hospitalization [16, 17]. How-
ever, it is unclear whether there are long term effects
of common infections on cognition and dementia,
independent of delirium.
Previous reviews have investigated the role of bac-
terial pathogens on Alzheimer’s disease; however,
evidence is inconsistent, and the exact nature of this
association remains unclear. In a meta-analysis of
predominantly case-control studies Maheshwari and
Eslick found that Chlamydia pneumonia, a bacterium
responsible for pneumonia and other respiratory
tract infections, was associated with a five-fold (OR
5.66; 95% CI 1.83–17.51) increased occurrence of
Alzheimer’s disease [11]. However, due to the cross-
sectional nature of the data collected in these studies,
it was not possible to assess temporality. Additional
drawbacks of this meta-analysis included differences
in methodology and the relatively small sample sizes
of the studies included (total sample size ranging
from 2 to 200 samples). Furthermore, other bacte-
rial microorganisms have also been implicated in
previous and subsequent reviews [10, 18] and dif-
fering conclusions have been drawn on the role of
Chlamydia pneumonia with Alzheimer’s disease as
evidenced in a comprehensive review by Mawanda
and Wallace [18]. However, studies included in these
reviews also faced the same limitations in terms of
sample size and cross-sectional study designs.
We aimed to summarize current evidence from lon-
gitudinal studies of the association between common
clinically symptomatic bacterial infections (sepsis,
lower respiratory tract infections, urinary tract infec-
tions, and skin and soft tissue infections) and risk of
subsequent incident dementia or cognitive decline in
adults aged 18 years and older. A secondary objective
was to identify gaps in literature and recommenda-
tions for future research.
METHODS
Protocol and registration
We registered this systematic review with the
International Prospective Register of Systematic
Reviews in December 2018 (PROSPERO 2018;
CRD42018119294) and published a more detailed
protocol in accordance with the Preferred Report-
ing Items for Systematic Reviews and Meta Analyses
Protocols (PRISMA) reporting guidelines [19].
Study design
Studies eligible for inclusion were longitudinal
studies such as prospective and retrospective cohort
studies, secondary analyses of randomized controlled
trial data, and case control studies. We included stud-
ies in which cognitive decline was measured at least
3 months following infection, to avoid associations
dominated by short term, reversible cognitive impair-
ment. Further, to assess temporality, we restricted our
search to studies in which infections occurred prior
to cognitive decline or dementia.
Study population
Only studies with human participants aged 18
years and older were eligible for inclusion.
Exposure
Exposure was defined as symptomatic illness due
to common bacterial infections, either suspected
clinically or confirmed by isolation of a bacte-
rial pathogen. We identified studies investigating
the following major infection types: sepsis, lower
respiratory tract, skin and soft tissue, and urinary
tract infections. Studies identifying specific bacterial
agents alone, rather than the symptomatic disease,
were excluded.
Comparators
We only included studies in which a comparison
group was present. This comparison group comprised
of individuals unexposed to common bacterial infec-
tions in cohort studies and secondary analyses of
longitudinal randomized controlled trial data, or a
control group without dementia or cognitive decline
in case control studies.
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Outcomes
Our two primary outcomes of interest were (1) inci-
dent dementia (all types) and (2) cognitive decline.
We included studies in which our outcomes were
defined clinically, which for dementia could be
with or without neuroimaging or histopathology
results.
Information sources
We performed a comprehensive search across
eight databases of published literature (MEDLINE,
EMBASE, Global Health, PsychInfo, CINAHL Plus,
Cochrane Library, Scopus, and Web of Science) and
two grey literature databases (Open grey and the
British Library electronic Theses Online Service)
from inception to 18 March 2019. Additionally, we
searched the reference lists of the included studies
to identify any relevant articles not captured in our
search strategy.
Search
We searched the databases using subject head-
ings, specific to each database, and keywords related
to common bacterial infections, cognitive decline
or dementia, and longitudinal study designs. These
search terms were then combined using Boolean log-
ical operators. No restrictions were placed on the
language, country, or health care setting of the stud-
ies. Our search strategy was developed in consultation
with a librarian at the London School of Hygiene
and Tropical Medicine and was subsequently peer
reviewed based on the Peer-Review for Electronic
Search Strategies. We translated the final search
strategy across all databases which is shown in the
Supplementary Material 1.
Study selection
The study selection process was carried out by two
reviewers (RM and JAD), using the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
flow diagram. The two reviewers independently
screened all titles, abstracts and full text articles
against the eligibility criteria. A third reviewer
(CWG) was consulted when there were any discrep-
ancies.
Data items
Data extraction was performed independently by
two reviewers for all studies. We used the Popula-
tion, Exposure, Comparator, Outcomes and Study
characteristics framework to extract data from eli-
gible studies (Supplementary Material 2). We pilot
tested our data extraction form and modified the
form accordingly. We extracted key study results,
namely unadjusted and adjusted incidence effect esti-
mates and their corresponding 95% CIs. Data on
confounding variables adjusted for in each study and
pre-specified sub-groups were also extracted.
Risk of bias in individual studies
The risk of bias was assessed independently by
two reviewers in line with the Cochrane collaboration
approach. We classified studies as at high, medium,
low or unclear risk of bias in each of the follow-
ing domains: confounding, selection of participants,
misclassification of variables, missing data, reverse
causation, generalizability, and study power [20, 21].
Synthesis of results
We grouped studies according to their outcome
(cognitive decline or dementia) and exposure defi-
nition (common bacterial infection) and synthesized
them narratively. Heterogeneity was assessed using
the I squared statistic if there were two or more
studies with effect estimates for the same exposure
definition, outcome, and study design. Geographical
location and risk of bias were explored as potential
sources of heterogeneity. Other sources of hetero-
geneity could not be explored due to the limited data
available. We also carried out sub-group analyses by
age, sex, and dementia subtype where sufficient data
were available.
Quality of evidence
We assessed the overall quality of evidence for
each outcome using the Grading of Recommen-
dations, Assessment, Development and Evaluation
(GRADE) tool. The following domains were
assessed: study limitations, inconsistency, indirect-
ness, imprecision, and publication bias. We rated the
strength of evidence as high, moderate, low, or very
low. The criteria for grading are stated in Supplemen-
tary Material 3.
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Fig. 1. Study selection PRISMA flow diagram.
RESULTS
Study characteristics
In total, 3,488 studies were identified from 10
databases, after de-duplication, as outlined in Fig. 1.
Of these, 42 were included in the full text screening
and the reasons for exclusion were noted. Finally,
9 studies were included in the present systematic
review. The study characteristics and results are sum-
marized in Tables 1 and 2, respectively. Forest plots
of the results are displayed in Figs. 2 and 3.
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Fig. 2. Forest plot showing the effect of infections on dementia. *Unadjusted effect estimates. The mean age (SD) in this study was 72.8
years (5.6).
Fig. 3. Forest plot showing the effect of common bacterial infections on cognitive decline. *Unadjusted effect estimates for the study by
Davydow et al., 2013 [26]. The median age in years (SD) in this study for each exposure was as follows: pneumonia 77.1 (9.4), myocardial
infarction, 75.5 (8.2) and stroke 77.0 (8.4).
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Of the studies included, six studies were conducted
in the United States [22–27], and three in Taiwan
[28–30]. Four were historical cohort studies, which
used data derived from electronic health records [22,
25, 28, 29], two were prospective cohort studies [23,
26], one was a secondary analysis from a random-
ized controlled trial [24], and two were case-control
studies [27, 30].
In total, seven studies investigated sepsis [22,
23, 25, 27–30], four assessed pneumonia [23–26],
and only one study considered urinary tract infec-
tions and cellulitis [25]. Two studies investigated the
effect of multiple infections on dementia [23, 25].
Infections were defined using ICD-9 (International
Classification of Diseases, Ninth Revision) or ICD-9-
CM (International Classification of Diseases, Ninth
Revision, Clinical Modification) codes [22–26, 29,
30]. Ascertainment of infection was unclear in two
studies [27, 28]. In terms of the setting in which
infections were diagnosed, all studies defined infec-
tions in secondary care, with the exception of one
study which included individuals receiving care at
veterans health administration facilities [25]. These
facilities comprise secondary care, outpatient sites
and primary care settings. Two studies reported on
the association between sepsis and dementia from
the same study population in the Taiwanese health
insurance database. Of these studies, one reported
on vascular dementia as an outcome [28], while
the other study reported on all types of dementia,
Alzheimer’s disease, and non-Alzheimer’s disease
dementia [29].
Ascertainment of dementia and cognitive decline
varied across studies. Four studies defined dementia
using the ICD-9 or ICD-9-CM diagnostic codes [22,
25, 29, 30], while two studies used multiple validated
clinical tests to diagnose dementia [23, 24]. One study
did not specify the ascertainment of dementia [28]. In
one study, cognitive decline was defined using a mod-
ified version of the Telephone Interview for Cognitive
Status, which is a validated measurement of cognitive
impairment [26]. The other study ascertained cogni-
tive impairment through manual review of medical
records, and the use of algorithms to capture terms
for cognitive impairment and dementia [27].
Sample sizes were generally smaller for studies
assessing cognitive decline, ranging from 1,434 to
2,401 total population, compared to 3,602 to 417,172
in dementia studies. The age at which participants
were recruited ranged widely between 18 to 75 years
and older, but the mean age ranged between 65.5 to
78.6 years old.
The duration of follow up differed widely. In stud-
ies assessing cognitive decline, follow-up ranged
from 3 months to 9.8 years. Among studies assessing
dementia, only 3 studies reported the mean or median
follow time which ranged from 2.5 to 9.0 years.
Effect of infections on dementia
Seven studies assessed dementia as an outcome
(Table 2, Fig. 2) [22–25, 28–30]. In all studies, infec-
tions were associated with an increased risk of all
cause dementia or vascular dementia, with effect esti-
mates ranging from HR 1.10 (95% CI;1.02–1.19) to
OR 2.60 (95% CI;1.84–3.66).
To determine whether a meta-analysis was appro-
priate, we calculated heterogeneity when a sufficient
number of studies were available. We decided not
to meta-analyze data for the associations between
sepsis or pneumonia with incident dementia due
to evidence of substantial heterogeneity, I2 = 93.6%,
p = <0.01 and I2 = 83.9%, p < 0.01. Due to the lim-
ited number of studies available, we could only
explore geographical location and risk of bias as
potential sources for heterogeneity. Heterogeneity
was explored in studies assessing incident dementia
following sepsis infection as shown in Supplemen-
tary Figures 1 and 2. Removing studies conducted in
Taiwan reduced heterogeneity substantially (I2 = 0%,
p = 0.406); however, when studies with a domain
of high risk of bias were removed, heterogeneity
remained high (I2 = 95.6%, p < 0.01).
Subgroup analyses
All three studies from Taiwan reported data on
subgroup analyses for age, sex, and dementia sub-
type as shown in Supplementary Figures 3–5. Of
these, two studies reported on the association of
sepsis on dementia subtype [28, 29]. In one study,
sepsis was associated with an increased risk of all
types of dementia 2.09 (95% CI; 1.92–2.28) and non-
Alzheimer dementias 2.20 (95% CI; 2.01–2.41) [29].
However, the association of sepsis and Alzheimer’s
disease HR 1.15 (95% CI; 0.83–1.60) was not sta-
tistically significant. In the other study, individuals
with sepsis had an increased risk of vascular demen-
tia HR 2.26 (95% CI; 2.07–2.47) [28]. In sub-group
analysis we also explored whether the effect of infec-
tions on dementia differed by sex [29, 30]. Findings
from these studies showed the association of sepsis
on dementia was greater in men compared to women.
1620 R. Muzambi et al. / Bacterial Infections, Cognition, and Dementia
Table 3
Risk of bias summary assessments for individual domains
Only one study investigated the effect of age
on infections and dementia [30]. Kao et al. found
that compared with individuals aged 45 to 64, par-
ticipants aged 65 and older showed a lower risk
of dementia following sepsis HR 1.80 (95% CI;
1.65–1.97) than those aged under 45 HR 7.32 (95%
CI; 1.85–28.9). However, these results are difficult
to interpret due to the small number of events in the
under 45 years age group (n = 11) compared to the
65 years and older group (n = 2492). This study also
investigated the effect of sepsis severity on demen-
tia and found that dementia incidence increased with
mild HR 1.20 (95% CI; 1.06–1.37), moderate HR
3.37 (95% CI; 3.02–3.76) and severe HR 5.04 (95%
CI; 3.98–6.37) sepsis severity. Another study also
reported an increasing trend for developing dementia
with increasing sepsis severity [28].
Effect of infections on cognitive decline
Two studies assessed cognitive decline as an out-
come: one following hospitalization with pneumonia
and the other following admission to an intensive
care unit with sepsis (Table 2, Fig. 3) [26, 27]. In
one study, the effect of pneumonia hospitalization on
moderate/severe cognitive impairment was compared
to individuals hospitalized with stroke OR 0.64 (95%
CI; 0.3–1.34) and to those with myocardial infarc-
tion OR 1.46 (95% CI; 0.69–3.09) [26]. In the other
study, there was no association between sepsis and
cognitive decline OR 1.08 (95% CI; 0.97–1.21) in
adjusted estimates [27]. Given that the definition of
infections was inconsistent in these studies, we could
not pool the results into a combined effect estimate
and perform a meta-analysis.
Risk of bias
Our classifications and justifications for the risk
of bias assessments are presented in Supplementary
Table 1 and summarized in Table 3. Overall, none
of the studies were classified as at low risk of bias
across all domains. All studies assessing cognitive
decline and three looking at dementia outcomes were
considered at high risk of bias for study power. Stud-
ies assessing cognitive decline had particularly small
sample sizes and wide confidence intervals com-
pared to the dementia studies. The majority of studies
assessing dementia scored a low risk of bias for con-
founding as these studies adjusted for age, sex, and
other important covariates. Three studies did not have
any domains at high risk of bias [22, 25, 29]. These
studies all investigated the effect of sepsis on demen-
tia, with hazard ratios ranging from 1.39 (95% CI;
1.16–1.66) to 2.09 (95% CI; 1.92–2.28). All studies
were given a low rating for reverse causality as all out-
comes were assessed after infection; however, three
studies reported a relatively short follow up period
from infection to dementia diagnosis [22, 24, 30].
Given that dementia has a long pre-clinical phase, it is
thus unclear whether follow up time was long enough
for dementia to develop. Further, none of the studies
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reported sufficient information on loss of follow up
or how missing data were accounted for.
Study quality
The overall evidence on the associations of sep-
sis or pneumonia with dementia were classified as of
very low quality using the GRADE assessment tool.
This is because these studies were rated “serious” or
“very serious” for risk of bias, inconsistency, impre-
cision, and indirectness (Supplementary Table 2). We
did not assess the overall quality of evidence for the
association of other infections on dementia or cogni-
tive decline as only a single study was available for
each exposure and outcome.
DISCUSSION
Our comprehensive systematic review identified
9 longitudinal studies examining the association of
common bacterial infections with incident dementia
or cognitive decline. Although a meta-analysis was
not performed due to the heterogeneity of the studies,
evidence from all seven studies assessing dementia
found a positive association following infection with
sepsis, pneumonia, urinary tract infections, or celluli-
tis. This association remained consistent in studies
with no domains at high risk of bias. However, the
overall quality of evidence was rated very low for
these studies due to risk of bias, consistency, impre-
cision, and indirectness. Of the two studies assessing
the effect of pneumonia or sepsis on cognitive decline,
a lack of association was observed. However, these
studies had a number of important methodologi-
cal limitations including a lack of power or poor
comparability, limiting the ability to draw accurate
conclusions from the findings.
Heterogeneity
The high heterogeneity observed between the
studies assessing incident dementia precluded a
meta-analysis, despite the studies being homoge-
nous in terms of exposure, outcome, and study
design. A major source of heterogeneity may have
been the differences in the country in which the
study was conducted. Studies assessing the effect
of sepsis on dementia were either from the United
States or Taiwan, with studies from Taiwan report-
ing much greater effect estimates compared to those
from the United States. When studies from Taiwan
were removed from the meta-analysis, heterogeneity
reduced substantially. However, due to the small
number of studies available, we were unable to
quantitatively explore heterogeneity in studies from
Taiwan. Studies assessing pneumonia were all con-
ducted in the United States, but also had high
heterogeneity, however, the paucity of studies lim-
ited the ability to quantitatively explore sources of
the heterogeneity.
There are a number of possible explanations
for the substantial heterogeneity observed. Varying
assessments were used to diagnose dementia includ-
ing neuropsychological tests, ICD-9 or ICD-9-CM
codes, and magnetic resonance imaging. Studies
using electronic health records rely on routine med-
ical diagnoses which can result in misclassification
given that dementia is frequently under-diagnosed
in these databases [31, 32]. However, further evi-
dence suggests that recording of dementia diagnoses
is changing over time, with improvements observed
in more recent years [33, 34]. Another potential issue
arising from routine healthcare data is that individ-
uals with illnesses encounter health services more
frequently compared to healthy people, which could
increase the likelihood of getting a dementia diag-
nosis. This may, however, be more likely to occur
among those with chronic illnesses requiring ongoing
management than with acute infections.
Another source of heterogeneity could have come
from differences in the adjustment of confounders,
given that the study that adjusted for a wide range
of confounders including demographics, psychiatric
and medical comorbidity reported weaker effect
estimates in comparison to the other studies [25].
Additionally, differences in the age at recruitment and
mean age of the study populations may also account
for the heterogeneity. This is of importance as the
risk of developing infections increases with age [35]
and in turn older adults have a greater chance of
developing dementia, with the risk doubling every
5 years after the age of 65 [36]. Additionally, sex
representation, which ranged from 44% to 97% for
men, may have contributed to heterogeneity. In our
subgroup analyses, we observed differences in sex
in the Taiwanese studies looking at the association
between sepsis and dementia, with men at a greater
risk of dementia compared to women [29, 30]. Studies
from Europe and the United States suggest that there
is gender variation in the reduction of age-specific
dementia, with some reporting a greater decline in
men [3, 6, 9] and others in women [5, 8].
One study did not find an association between sep-
sis and Alzheimer’s disease. The study suggested a
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reason for this may be due to the low prevalence
for a causative pathogen of Alzheimer’s disease, B.
burgdorferi, in Taiwan [29]. Another reason could
be the potential to misdiagnose Alzheimer’s dis-
ease. A systematic review investigating the validation
of dementia cases in routine health care data from
Europe, North America, and Australia found that pos-
itive predictive values of Alzheimer’s disease ranged
from 57% to 100% [37].
Cognitive decline
Evidence for any association of common bacterial
infections with cognitive decline was limited. The
study by Davydow et al. faced a number of limita-
tions. First, there was no adjustment for confounders
in this study [26]. Second, individuals hospitalized
with pneumonia were compared to those with stroke
and myocardial infarction. This raises issues on the
suitability of these comparator groups as stroke and
myocardial infarction are both risk factors for demen-
tia and may increase the risk of pneumonia [38, 39].
The authors stated that these analyses were based on
a hypothetical population, and as such the results may
not be generalizable to a particular group of people.
Taken together, these limitations make it difficult to
extrapolate any meaningful conclusions from these
results.
Comparison with previous studies
Although the association between common bac-
terial infections and cognitive decline was unclear,
evidence from previous longitudinal studies suggests
that individuals with bacterial infections are associ-
ated with worsening cognitive impairment [16, 40],
with one study showing a decline in the mean score
of cognitive ability, assessed using the Danish intel-
ligence test, following hospitalization with sepsis,
skin, respiratory and urological infections [41]. Other
studies have found a link between sepsis and spe-
cific cognitive domains after long-term follow up
[42].
Regarding the link between bacterial infections
and dementia, our findings are consistent with evi-
dence from a nested-case control study using UK
primary care data which suggested that episodes of
infections were associated with an increased like-
lihood of a dementia diagnosis [43]. This study
assessed the overall effect of infections on dementia,
including urinary tract and skin infections, rather than
the individual effect of each infection on dementia.
Because of this, the study was not eligible for inclu-
sion.
Individual bacterial pathogens including Heli-
cobacter pylori, Chlamydia pneumoniae, Borelia
burgdorferi, and oral spirochetal Trepenoma have
been linked to Alzheimer’s disease, primarily in
serology based and post mortem brain studies [10,
18]. Chlamydia pneumonia and spirochetes are the
focus of previous reviews and have been frequently
associated with Alzheimer’s disease [10, 11, 44–46].
In their review, Mawanda and Wallace suggested
chronic bacterial infections, such as tuberculosis, are
associated with amyloid deposition, a key hallmark
of Alzheimer’s disease. This is further supported in
a study by Emery et al., which demonstrated an
increase in actinobacteria in the brains of individuals
with Alzheimer’s disease compared to controls [47].
However, no single microorganism has been identi-
fied as the sole pathogen responsible for Alzheimer’s
disease.
Mechanisms
Mechanisms underlying the association between
infections and subsequent dementia are unclear
[48, 49], but several plausible pathophysiological
pathways have been proposed. One such potential
pathway is through systemic inflammation. Infec-
tions can induce systemic inflammation through
the release of pro-inflammatory mediators which
can cross the blood-brain barrier and activate cyto-
toxic microglia. This may result in a deterioration
of cognitive function and thus increasing the risk
of developing dementia [10]. In support of this
mechanism, evidence from a growing number of lon-
gitudinal studies suggests that markers of systematic
inflammation, such as tumor necrosis factor, nitric
oxide synthase, and interleukin IL-1, IL-6, and IL-
18, are involved in the pathogenesis of dementia [50,
51]. Recent findings demonstrate that when sepsis is
induced in animal models, it triggers systemic inflam-
mation which leads to accumulation of amyloid-
and cognitive dysfunction [52, 53].
Alternatively, it is also possible that the associa-
tion between infections and dementia is non-causal
and may be a result of the co-occurrence of age-
related pathologies. The immune system deteriorates
with age, increasing incidence of infection. Con-
versely, the aging immune system also induces a
chronic inflammatory state which leads to tissue
damage and inflammatory disease and accelerates
age-related diseases such as Alzheimer’s disease
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[54, 55]. Nevertheless, the present review focused
only on longitudinal studies which provide evidence
of appropriate temporality between infections and
dementia, thus adding to the likelihood of a possible
causal relationship.
Strengths and limitations
Strengths of our study include a comprehensive
search using multiple databases of published and grey
literature, with no restrictions on the date, language
or geographical location of the studies. Our search
strategy was detailed and peer reviewed. We regis-
tered and published our protocol in order to increase
the transparency of our findings. Other strengths
include the inclusion of longitudinal studies to mini-
mize reverse causality, a minimum 3 month follow up
period to avoid capturing short term cognitive impair-
ment, and requiring the use of a comparator group
without infections in order to provide evidence on
causality.
There are several limitations to this systematic
review. First, there was a small number of longi-
tudinal studies available, particularly for cognitive
decline outcomes. Second, the high heterogeneity
between the studies meant that it was not feasible
to perform a meta-analysis. Third, given the long
pre-clinical phase of dementia and the evidence that
individuals with dementia are at a greater risk of hos-
pitalizations and common bacterial infections [56],
we cannot rule out the possibility of reverse causality.
Fourth, these studies did not account for past hospi-
talizations with infections, as such we cannot rule out
the effect of previous infections on the risk of demen-
tia. Fifth, the generalizability of these studies is of
concern. All studies were conducted in the United
States or Taiwan, and there were no studies from
Europe or low- or middle-income countries. Further
to this, infections were predominantly diagnosed in a
hospital setting. These findings may thus not be rep-
resentative of individuals with less severe infections
that did not require hospitalization. This may have
led to an underestimation of people with infections.
Implications for research and practice
The paucity of studies available highlights the need
for further large scale, longitudinal studies from pop-
ulations across the world.
Our sub-group analyses suggested that the sever-
ity of sepsis is associated with an increased risk of
dementia. Further research on the effect of sever-
ity, frequency, and timing of infections on cognitive
decline and dementia is warranted. This will be
important for identifying the sub-populations most at
risk of dementia. In line with this rationale, previous
studies have identified a dose-response relationship
between hospital contacts with infection and cogni-
tive ability [41]. Additionally, there is evidence of
gender variation between infections and dementia,
as such, more work is needed to explore this possible
link further as it may have implications on prevention
strategies in men and women.
A key drawback of the studies included was the
fact that infections were predominantly diagnosed
in secondary care. This is an issue as hospitaliza-
tion itself has been associated with incident cognitive
decline and dementia [57–59]. Hospitalized patients
are at a greater risk of nosocomial infections [60],
delirium [61], and functional decline [62], which
may also increase the risk of dementia. Therefore,
individuals hospitalized with infections may not be
representative of those with infections diagnosed in
primary care. In future, studies could investigate the
effect of infections diagnosed in different health care
settings. Additionally, the bacterial agents responsi-
ble for infections acquired in the community or in
hospital settings differ, and as such it is possible
that these pathogens could have differing effects on
dementia, if any at all. Future longitudinal studies
investigating the link between laboratory confirmed
bacterial agents and dementia could shed further light
on causality.
Research on infections as potential risk factors for
dementia faces a number of challenges. Firstly, the
etiology of dementia is multifactorial and is likely to
involve an interplay of genetic, environmental, and
lifestyle factors. In addition, the fact that age is the
single greatest risk factor for dementia raises chal-
lenges in disentangling the pathophysiological effects
of age on dementia with the independent effects of
infections on dementia. Secondly, the pathophysio-
logical processes of dementia may begin years before
dementia is diagnosed, and as such it is possible that
the preclinical phase of dementia may be underway
before infection occurs. Future studies with a follow
up time sufficient enough for dementia to develop
are recommended in order to minimize the possibility
of reverse causality. Moreover, given that infections
may trigger delirium, it is important for future stud-
ies to ensure that individuals are followed up long
enough for delirium to resolve in order to help dis-
tinguish between delirium and long-term cognitive
decline. However, as delirium itself is associated with
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cognitive decline and dementia, there is a need to bet-
ter understand whether the pathological processes of
infections on long-term cognitive decline are inde-
pendent of delirium. Third, prospective cohort studies
on infections and dementia are susceptible to selec-
tion bias. Individuals with more severe infections are
associated with attrition as they are more likely to
experience greater morbidity and an increased risk of
mortality compared to those with less severe infec-
tions. Additionally, cognitive decline and dementia
are associated with attrition during follow up and
drop-out due to death [63, 64], which may underesti-
mate the true effect of infections on dementia. Further
studies could tackle this limitation by performing an
analysis of attrition to investigate whether those lost
to follow up were more likely to have impaired cog-
nitive function. Loss of follow up is minimized in
routine healthcare datasets; however, one of the limi-
tations of these datasets is that they rely on individuals
seeking health care services. As a result, health seek-
ing behavior could affect the likelihood of a dementia
diagnosis. Future studies should consider account-
ing for health-seeking behavior in their design or
analysis.
This review suggests that infections may be
involved in the development of dementia. These find-
ings could have clinical implications in the early
recognition and treatment of infections, particularly
in the older population who are more susceptible
to infections and are at a greater risk of dementia.
Additionally, other implications include the need for
strategies to improve infection control and to identify
sub-populations at risk of infections and dementia.
Conclusions
Our systematic review suggests that sepsis, pneu-
monia, urinary tract infections, and cellulitis may be
associated with an increased risk of dementia, after
adjustment for multiple confounders. However, due
to the paucity of longitudinal studies, further evidence
from high quality studies is needed to confirm this
association. Given that evidence on cognitive decline
was limited by a lack of studies and small sample
sizes, further large scale, well-powered studies are
needed to investigate the effect of infections on cogni-
tive decline. Infections are well-recognized to trigger
delirium, as such, it is important for future work to
distinguish whether the potential association between
infections and cognitive decline is independent of
delirium. Common bacterial infections frequently
occur in the elderly, who are at an increased risk of
dementia, and thus a better understanding of their role
in dementia development could inform dementia risk
reduction strategies.
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